RHÖN-KLINIKUM AG 

22.11.2013 09:45

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.



Notification according to section 26 para. 1 WpHG 

B. Braun Melsungen Aktiengesellschaft, Melsungen, Germany notified us
pursuant to section 21 para. 1 WpHG, section 25 para. 1 WpHG, section 25a
para. 1 WpHG and section 27a para. 1 WpHG of the following:

1) B. Braun Melsungen Aktiengesellschaft notified us pursuant to section 21
para. 1 WpHG of the following:
On 21 November 2013, B. Braun Melsungen Aktiengesellschaft exceeded the
threshold of 10% of the voting rights in RHÖN-KLINIKUM Aktiengesellschaft,
Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, B.
Braun Melsungen Aktiengesellschaft held 14.00% of the voting rights in
RHÖN-KLINIKUM Aktiengesellschaft arising from 19,345,713 voting rights
which are held directly by B. Braun Melsungen Aktiengesellschaft.

2) B. Braun Melsungen Aktiengesellschaft notified us pursuant to section 25
para. 1 WpHG of the following:
On 21 November 2013, B. Braun Melsungen Aktiengesellschaft exceeded the
threshold of 10% of the voting rights in RHÖN-KLINIKUM Aktiengesellschaft,
Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, B.
Braun Melsungen Aktiengesellschaft held 14.00% of the voting rights in
RHÖN-KLINIKUM Aktiengesellschaft arising from 19,346,713 voting rights.
From these voting rights a proportion of 14.00% (equals 19,345,713 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG and a
proportion of 0.001% (equals 1,000 voting rights) is based on (financial /
other) instruments pursuant to section 25 WpHG. From the voting rights
based on instruments pursuant to section 25 WpHG a proportion of 0% (equals
0 voting rights) is held indirectly (expiration date of the instruments
pursuant to section 25 WpHG: 22 December 2014).

3) B. Braun Melsungen Aktiengesellschaft notified us pursuant to section
25a para. 1 WpHG of the following:
On 21 Novemvber 2013, B. Braun Melsungen Aktiengesellschaft exceeded the
threshold of 10% of the voting rights in RHÖN-KLINIKUM Aktiengesellschaft,
Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, B.
Braun Melsungen Aktiengesellschaft held 14.00% of the voting rights in
RHÖN-KLINIKUM Aktiengesellschaft arising from 19,347,713 voting rights.
From these voting rights a proportion of 14.00% (equals 19,345,713 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG and a
proportion of 0.001% (equals 1,000 voting rights) is based on (financial /
other) instruments pursuant to section 25 WpHG. From the voting rights
based on instruments pursuant to section 25 WpHG a proportion of 0% (equals
0 voting rights) is held indirectly. In addition, a proportion of 0.001%
(equals 1,000 voting rights) is based on (financial/other) instruments
pursuant to section 25a WpHG. From the voting rights based on instruments
pursuant to section 25a WpHG a proportion of 0% (equals 0 voting rights) is
held indirectly. The instruments pursuant to section 25a WpHG are sold put
options ('Verkaufte Put-Optionen') with expiration date 22 December 2014.

4) B. Braun Melsungen Aktiengesellschaft ('Notifying Person') has informed
RHÖN-KLINIKUM AG on November 21, 2013, that its voting interest in
RHÖN-KLINIKUM AG has exceeded the threshold of 10% on November 21, 2013.
With respect to the objectives pursued with the acquisition of the voting
rights, the Notifying Person has informed us on November 21, 2013, pursuant
to Section 27a(1) of the German Securities Trading Act
(Wertpapierhandelsgesetz - WpHG) as follows:

1. The investment is used to implement strategic objectives. 
2. Within the next twelve months, the Notifying Person intends - within its
plan to sustainably secure its minority shareholding in RHÖN-KLINKUM AG -
to obtain further voting rights by acquisition or any other way.
3. The Notifying Person intends to obtain a representation on the
supervisory board of RHÖN-KLINIKUM AG relative to the significance of its
shareholding in RHÖN-KLINIKUM AG. Beyond that, the Notifying Person does
not intend to influence the composition of the administration, management
or supervisory board of RHÖN-KLINIKUM AG.
4. The Notifying Person does not intend to change the capital structure of
RHÖN-KLINIKUM AG, especially with regards to the ratio of internal/outside
financing and the dividend policy.
5. The Notifying Person has used partly own funds and predominantly
external funds in order to finance the purchase of the voting rights.

Bad Neustadt a.d. Saale, 22 November 2013

The Board of Management

________________________________________________________________

Dr. Kai G. Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 - 1318
Fax: +49 9771 99 - 1736



22.11.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


 
Language:     English
Company:      RHÖN-KLINIKUM AG
              Schlossplatz 1
              97616 Bad Neustadt a.d.Saale
              Germany
Internet:     www.rhoen-klinikum-ag.com
 
End of Announcement                             DGAP News-Service